期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Heart Lung and Circulation LetPub Score 5.1
50 ratings
Rate
Reputation 6.2 Influence 3.8 Speed 6.9 | ||||||||||||||||||||
期刊簡稱 | HEART LUNG CIRC | ||||||||||||||||||||
ISSN | 1443-9506 | ||||||||||||||||||||
E-ISSN | 1444-2892 | ||||||||||||||||||||
h-index | 38 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.heartlungcirc.org/ | ||||||||||||||||||||
在線稿件提交 | http://ees.elsevier.com/hlc/default.asp | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Elsevier Ltd | ||||||||||||||||||||
主題領域 | CARDIAC & CARDIOVASCULAR SYSTEMS | ||||||||||||||||||||
出版國/地區 | AUSTRALIA | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 2000 | ||||||||||||||||||||
每年文章數 | 158每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 9.82% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1443-9506%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 11.9 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy 來自Elsevier的數據: 26% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Heart Lung and Circulation] 的評論 | 撰寫評論 |
作者: 稻妻娅楠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-12 20:38:48 評論於 I feel that the most time-consuming part is not being able to find reviewers, and sometimes reviewers don't want to review or keep changing(0) 讚! | 稻妻娅楠 |
作者: 松风慧慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-22 14:37:55 評論於 4 months to go(0) 讚! | 松风慧慧 |
作者: DICK18 領域: 医学 審稿時間: 6.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-18 23:49:11 評論於 Bad review, very slow speed.(0) 讚! | DICK18 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:12:36 評論於 ORCID is the Open Researcher and Contributor ID, and it is an open non-profit organization. The ORCID ID is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all their relevant research activities(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:41:14 評論於 ORCID is currently optional, not mandatory. It is important to note that most publishers (including Elsevier, Wiley, Nature, Thomsen Reuters) now require all researchers associated with their publications to use an ORCID iD. 19. How to add ORCID ID if the article has been published without it? ORCID stands for Open Researcher and Contributor ID. The ORCID iD is a unique and persistent academic identity for authors, distinguishing them from other researchers and recording all their relevant research activities. You need to log in to each author's account and then link them in the account information modifications(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:13:55 評論於 Is it necessary to provide the ORCID iD for each author when submitting a manuscript?(0) 讚! | 修然小公主 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:28:00 評論於 What is ORCIDID? How to register?(0) 讚! | 修然小公主 |
作者: 南川天容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-03 11:10:25 評論於 Review speed: 3.0 | Submission success rate: 50.0 Experience sharing: A very slow journal, submitted to the editor for 2 and a half months and rejected without comments(0) 讚! | 南川天容 |
作者: 逍遥雪柏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-14 16:25:13 評論於 Bro, how is your article going now?(0) 讚! | 逍遥雪柏 |
作者: 苍风沛海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-15 15:28:12 評論於 Has anyone submitted this for two months and it is still "with editor"?(0) 讚! | 苍风沛海 |
作者: Clare Trevelyan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-06 21:49:04 評論於 A very niche magazine(0) 讚! | Clare Trevelyan |
作者: 瑛琭来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-17 09:47:21 評論於 Submission success rate: 25.0 Experience sharing: I calculated that there were over 300 submissions in early April, receiving about 1000 submissions in a year, with over 200 articles published annually, resulting in a success rate of about 20% - 30%(0) 讚! | 瑛琭来了 |
作者: 金刚正豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-19 17:33:15 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Just got a review, submitted in May, first review took two and a half months, minor revisions, revised in early September, made two format changes during this period, accepted in mid-September, total duration of 4 months(0) 讚! | 金刚正豪 |
作者: 宗室岳阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-05 08:47:38 評論於 It took a long time~ About 4 months. Asked for the manuscript twice~ Ended tragically~(0) 讚! | 宗室岳阳 |
作者: 宗室岳阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-02 16:43:31 評論於 It's too slow~ Submitted on March 27, under review on April 3, still waiting~ Praying for direct acceptance, sigh! Major revisions are also acceptable~(0) 讚! | 宗室岳阳 |
作者: 宗室岳阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-04-23 19:45:30 評論於 Submitted on March 27th, under review since April 3rd, still waiting~~ Hoping for acceptance, sigh! A major revision is also possible~~(0) 讚! | 宗室岳阳 |
作者: 冬马元灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-07-20 18:27:38 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: I think it's pretty good, even though a lot of comments were made, the attitude was still good(0) 讚! | 冬马元灵 |
作者: 终幕困顿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-07-10 17:54:30 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: Is this magazine charging??(0) 讚! | 终幕困顿 |
作者: 澄静春涛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-03-25 12:19:27 評論於 Do you collect meta?(0) 讚! | 澄静春涛 |
作者: 澄静春涛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-03-25 09:51:37 評論於 Review Speed: 1.0 Experience Sharing: I wrote a letter, thinking it was just that, but the reviewer came back with many questions. I patiently replied to each one and it was eventually accepted. The efficiency was okay, but the editor-in-chief was very welcoming(0) 讚! | 澄静春涛 |
作者: 华清如仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-17 18:33:09 評論於 Do you accept meta?(0) 讚! | 华清如仪 |
作者: 奉天骞仕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-03-13 20:58:05 評論於 It's not difficult. Our junior fellow just published an article. Tong F, Li ZQ, Li L, Chong M, Zhu YB, Su JW, Liu YL.The follow-up surgical results of coarctation of the aorta procedures in a cohort of Chinese children from a single institution. Heart Lung Circ. 2014 Apr;23(4):339-46. Heart, lung & circulation NLM abbreviation: Heart Lung Circ NLM ID: 100963739 Country of publication: Australia Location of publication: Chatswood, NSW, Australia Publisher: Elsevier Australia Publication frequency: Bimonthly Year founded: 2000 Language: English SCI indexed: YES ISSN: 1443-9506 (Print) 1444-2892 (Electronic) 1443-9506 (ISSNLinking) Currently indexed in: IM PubMed indexed: YES Research areas: Cardiovascular diseases, heart disease, lung disease, vascular disease(0) 讚! | 奉天骞仕 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-01-02 17:10:47 評論於 The author instructions of this magazine say that decisions are typically made within six weeks(0) 讚! | 凌霄高洁 |
作者: 元嘉三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-10-22 10:56:14 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: A garbage journal, after a major revision, was rejected after being submitted for 4 and a half months!! It's a waste of time(0) 讚! | 元嘉三岁啦 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us